Police to Score UK Train Operators on Sexual Harassment Prevention No Financial Penalties for Missing Targets Spotify Shares Surge on AI Music Partnership with UMG and Upbeat Guidance Berkshire Hathaways March Tiny Purchase Potentially Revealed in Latest Filing Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Hurdles CD Rates Reach Up to 4 APY as Savings Yields Remain Attractive Perpetua Resources Secures 29 Billion Loan from US ExportImport Bank for Idaho Critical Minerals Project Lifeway Foods Inc LWAY Q1 2026 Earnings EPS Slightly Misses Estimates Amid Modest Stock Advance Ethos Technologies Inc LIFE Q1 2026 Earnings EPS Surges 138 Above Estimate Yet Stock Declines Sharply Balchem Q1 2026 Earnings Slight EPS Miss Amid Flat Stock Reaction ROG Q1 2026 Earnings Strong EPS Beat Surprises Market TRI Q1 2026 Earnings EPS Beats Estimates by 178 Stock Declines Despite Profit Surprise SYPR Q3 2025 Earnings Return to Profitability with EPS of 002 PicoCELA Inc PCLA Surges Over 190 in Massive Rally Key Levels to Watch Elemental Royalty Corporation ELE Holds Ground Near Resistance Key Levels in Focus Super League Enterprise Plunges 11 as Bears Take Control Below 463 Resistance ArrowMark Financial Corp BANX Holds Near Support as Slight Downtick Persists M Evo Global Acquisition Corp II Warrants MEVOW Holds Steady at 039 as Warrants Trade Near Support LEN Q1 2026 Earnings Lennar Misses EPS Estimates Despite Marginal Stock Gains SPOT Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment KNSL Q1 2026 Earnings EPS Surprises 672 to the Upside Stock Slips Polaris Inc PII Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment After Challenging Quarter C3ai Q1 2026 Earnings WiderThanExpected Loss and Tepid Market Reception CLNE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Management Efforts Huawei Unveils Advanced Chip Design Method Plans New Smartphone Chips This Fall Amid Intensifying Rivalry With Nvidia and Apple LNC Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher NewAmsterdam Pharma NAMS Slightly Lower Amid Consolidation Near Key Support Levels